Identification
- Summary
Medical air is a mixture of gases that is primarily composed of nitrogen and oxygen used for respiratory support in a variety of conditions.
- Generic Name
- Medical air
- DrugBank Accession Number
- DB09337
- Background
Medical air is supplied by a special air compressor to patient care areas using clean outside air.
- Type
- Small Molecule
- Groups
- Approved, Vet approved
- Synonyms
- Air
- Air medicinal
- Air, Compressed
- Air, medicinal
- Air, synthetic medicinal
Pharmacology
- Indication
For use as a source of clean air Label.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prevention of Hypoxia •••••••••••• ••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Acts as a source of clean air to support respiration Label.
- Mechanism of action
Air is approximately 21% oxygen which enters the body through the lungs, crossing the alveolar membrane to reach systemic circulation 1. One there it is bound by hemoglobin and transported to tissues thoughout the body where it is used as a terminal electron acceptor in oxidative phosphorylation. This allows efficient generation of adenosine triphosphate, the primary storage molecule for energy, in the mitochondria.
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Air Gas 1000 mL/1L Respiratory (inhalation) Middlesex Gases And Technologies, Inc. 2011-02-01 Not applicable US 
Air Gas 1000 mL/1L Respiratory (inhalation) Praxair Distribution, Inc. 2002-05-01 Not applicable US Air Gas 1000 mL/1L Respiratory (inhalation) Airgas Intermountain Inc 1958-01-01 Not applicable US Air Gas 1000 mL/1L Respiratory (inhalation) Hartman Brothers, Inc. 2010-04-09 Not applicable US Air Gas 100 L/100L Respiratory (inhalation) CEE-KAY SUPPLY, INC. 2005-08-01 Not applicable US - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Air Gas 990 mL/1L Respiratory (inhalation) General Air Service & Supply Co 1974-08-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Carbon Dioxide 1% W Air Medical air (85 %) + Carbon dioxide (15 %) Gas Respiratory (inhalation) Liquid Carbonic Inc. 1990-12-31 1998-06-09 Canada 
Carbon Dioxide 15.1% W Air Medical air (70 %) + Carbon dioxide (30 %) Gas Respiratory (inhalation) Liquid Carbonic Inc. 1990-12-31 1998-06-09 Canada Carbon Dioxide 30.1% W Air Medical air (50 %) + Carbon dioxide (50 %) Gas Respiratory (inhalation) Liquid Carbonic Inc. 1990-12-31 1998-06-09 Canada Carbon Dioxide USP, Compressed Air USP M.G.m Medical air (50 %) + Carbon dioxide (50 %) Gas Respiratory (inhalation) Praxair, Inc. 1993-12-31 Not applicable Canada Carbon Dioxide USP, Compressed Air USP M.G.m Medical air (70 %) + Carbon dioxide (30 %) Gas Respiratory (inhalation) Praxair, Inc. 1993-12-31 Not applicable Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Air Medical air (1000 mL/1L) Gas Respiratory (inhalation) Encompass Medical & Specialty Gases, Ltd. 2007-04-01 Not applicable US Air Medical air (1000 mL/1L) Gas Respiratory (inhalation) ILMO Products Company 2009-01-01 Not applicable US Air Medical air (1000 mL/1L) Gas Respiratory (inhalation) Fresno Oxygen & Welding Suppliers Inc 2005-01-01 Not applicable US Air Medical air (1000 mL/1L) Gas Respiratory (inhalation) Airgas East, Inc. 1991-01-15 Not applicable US Air Medical air (1000 mL/1L) Gas Respiratory (inhalation) Airgas Usa Llc 2000-09-20 2016-06-06 US
Categories
- ATC Codes
- V03AN05 — Medical air
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- K21NZZ5Y0B
- CAS number
- 132259-10-0
References
- General References
- Barrett KE, Barman SM, Boitano S, Brooks HL (2012). Ganong's Review of Medical Physiology (24th ed.). McGraw Hill. [ISBN:978-0-07-17803-2]
- External Links
- FDA label
- Download (106 KB)
- MSDS
- Download (327 KB)
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Acute Pain 1 4 Completed Treatment Chronic Obstructive Pulmonary Disease (COPD) 1 4 Recruiting Treatment Prader-Willi Syndrome / Sleep Apnea, Central 1 3 Completed Treatment Breech Presentation in Pregnancy 1 3 Terminated Treatment Anaesthesia 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gas Respiratory (inhalation) 100 L/100L Gas Respiratory (inhalation) 1000 mL/1L Gas Respiratory (inhalation) 20.5 L/100L Gas Respiratory (inhalation) 215 mL/1L Gas Respiratory (inhalation) 23 L/100L Gas Respiratory (inhalation) 99 L/100L Gas Respiratory (inhalation) 990 mL/1L Gas Respiratory (inhalation) 995 mL/1L Gas Respiratory (inhalation) 99 % Gas Respiratory (inhalation) 19.5 % v/v Gas Respiratory (inhalation) Gas Respiratory (inhalation) Gas Respiratory (inhalation) 100 % - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Gas
- Experimental Properties
Property Value Source melting point (°C) -216.2 MSDS boiling point (°C) -194.3 MSDS water solubility 0.0292 v/v at 0 °C MSDS - Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at November 27, 2015 00:14 / Updated at April 19, 2024 20:55